Ethical considerations and clinical trials during a pandemic: A blessing with a burden

Clinical Ethics 17 (4):331-333 (2022)
  Copy   BIBTEX


Any healthcare systems during a pandemic undergo tremendous pressure in pursuit of effective treatment to treat and limit the spread of the disease and its implications. Conducting clinical trials to find the potential therapy is the only way to battle the current coronavirus disease-2019 pandemic. The majority of the countries have joined the cause and are carrying out clinical studies in various capacities. As a result, the ethical committees have encountered a sudden inflow of a large number of trial proposals that have placed them under pressure. Although ethical committees play a vital role in protecting patient safety and preserving research integrity, they need to make sure the efficiency and integrity of review are preserved and the standards of review are not relaxed. Thus, the participants’ dignity is well guarded while keeping a close check on their safety.



    Upload a copy of this work     Papers currently archived: 91,271

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Ethics status of clinical research and trials in developing countries.Yuanyuan Liu - 2015 - Eubios Journal of Asian and International Bioethics 25 (4):124-127.
What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
Death and the Paradox of Blessing and Burden.William E. Stempsey - 2013 - Theoretical and Applied Ethics 2 (1):115-119.
Present and future.Jennifer Blumenthal-Barby - 2021 - Journal of Medical Ethics 47 (6):361-361.


Added to PP

7 (#1,332,392)

6 months
5 (#592,531)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references